During the month of April, the Butantan Institute (in Brazil) will export 925,000 doses of the flu vaccine to Uruguay and Nicaragua, after being awarded by the Pan American Health Organization (PAHO) tender notice.
As we reported, the vaccines will arrive in Uruguay in the second half of April. Although it is not a mandatory vaccine, the ministry always advises administering it to avoid infections by other viruses that circulate in cold months.
The institute reported in its website that this Tuesday 225,000 doses were sent to Nicaragua and the other 700,000 should be sent to Uruguay at the end of the month. This was possible thanks to the inclusion of the vaccine in the list of prequalified immunizers of the World Health Organization (WHO) in early 2021.
“The inclusion of the Butantan vaccine on the list is a recognition of Butantan’s good practices in the pharmacology, clinical studies, regulation, production and quality processes involved in the manufacture of the influenza vaccine,” says Butantan.
The current vaccine against influenza Butantan is trivalent, made up of the H1N1 virus, strain B and H3N2, of the Darwin subtype, which caused the localized outbreaks at the end of last year.
